Terence M. Berge Power - 28 Apr 2023 Form 4 Insider Report for CONMED Corp (CNMD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 May 2023, 16:12:30 UTC
Prior SEC filing
03 Mar 2023
Next SEC filing
05 Mar 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel S. Jonas for Terence M. Berge by Power of Attorney

Key filing fact

Terence M. Berge Power filed Form 4 for CONMED Corp (CNMD) on 02 May 2023.

Key facts

  • This page summarizes Terence M. Berge Power's Form 4 filing for CONMED Corp (CNMD).
  • 12 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 02 May 2023, 16:12.

Change

  • Previous filing in this sequence was filed on 03 Mar 2023.
  • Current net transaction value: -$1,005,316.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD transaction

Common Stock

Options Exercise

Transaction value
$117,404
Shares
+2,800
Change %
+279%
Price
$41.93
Shares after
3,804
Date
28 Apr 2023
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$323,784
Shares
+5,400
Change %
+142%
Price
$59.96
Shares after
9,204
Date
28 Apr 2023
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$425,304
Shares
+5,400
Change %
+59%
Price
$78.76
Shares after
14,604
Date
28 Apr 2023
Ownership
Direct
CNMD transaction

Common Stock

Options Exercise

Transaction value
$498,219
Shares
+5,100
Change %
+35%
Price
$97.69
Shares after
19,704
Date
28 Apr 2023
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$356,832
Shares
-2,800
Change %
-14%
Price
$127.44
Shares after
16,904
Date
28 Apr 2023
Ownership
Direct
Footnotes
F1
CNMD transaction

Common Stock

Sale

Transaction value
$684,612
Shares
-5,400
Change %
-32%
Price
$126.78
Shares after
11,504
Date
28 Apr 2023
Ownership
Direct
Footnotes
F2
CNMD transaction

Common Stock

Sale

Transaction value
$682,668
Shares
-5,400
Change %
-47%
Price
$126.42
Shares after
6,104
Date
28 Apr 2023
Ownership
Direct
CNMD transaction

Common Stock

Sale

Transaction value
$645,915
Shares
-5,100
Change %
-84%
Price
$126.65
Shares after
1,004
Date
28 Apr 2023
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-2,800
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,800
Exercise price
$41.93
Footnotes
F4
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-5,400
Change %
-100%
Price
$0.000000*
Shares after
0
Date
28 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,400
Exercise price
$59.96
Footnotes
F4
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-5,400
Change %
-67%
Price
$0.000000
Shares after
2,700
Date
28 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,400
Exercise price
$78.76
Footnotes
F5
CNMD transaction Derivative

Options To Purchase Common Stock

Options Exercise

Transaction value
$0
Shares
-5,100
Change %
-50%
Price
$0.000000
Shares after
5,100
Date
28 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,100
Exercise price
$97.69
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.25 to $127.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.60 to $127.23. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.54 to $126.99. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

Footnote F4

The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Footnote F5

The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .